MXD1 and colorectal cancer: The levels of MXD1 mRNA transcripts ranked the lowest in colorectal cancer (13 studies), leukemia (8 studies), esophageal cancer (5 studies) and head and neck cancer (4 studies) (Fig. S3I–N).